CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (UNAUDITED) - USD ($) $ in Thousands	Total	Common Stock	Accumulated Deficit
Balance, beginning of period at Jan. 30, 2021	$ 94,922	$ 174,391	$ (79,469)
Balance, beginning of period (in shares) at Jan. 30, 2021		14,292,250
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options	52	$ 52
Exercise of stock options (in shares)		10,669
Restricted stock issued		30,087
Net share settlement of stock options and restricted stock units	(257)	$ (257)
Net share settlement of stock options and restricted stock units (in shares)		(11,339)
Stock-based compensation expense	232	$ 232
Repurchase and retirement of common stock	$ (1,356)		(1,356)
Repurchase and retirement of common stock (in shares)	(47,350)	(47,350)
Net (loss) income	$ 1,719		1,719
Balance, end of period at May. 01, 2021	$ 95,312	$ 174,418	(79,106)
Balance, end of period (in shares) at May. 01, 2021	14,274,317	14,274,317
Balance, beginning of period at Jan. 29, 2022	$ 81,126	$ 175,856	(94,730)
Balance, beginning of period (in shares) at Jan. 29, 2022	12,631,347	12,631,347
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options	$ 16	$ 16
Exercise of stock options (in shares)		2,705
Restricted stock issued		797,849
Net share settlement of stock options and restricted stock units	(2,375)	$ (2,375)
Net share settlement of stock options and restricted stock units (in shares)		(224,320)
Stock-based compensation expense	548	$ 548
Repurchase and retirement of common stock	$ (6,253)		(6,253)
Repurchase and retirement of common stock (in shares)	(479,966)	(479,966)
Net (loss) income	$ (7,855)		(7,855)
Balance, end of period at Apr. 30, 2022	$ 65,207	$ 174,045	$ (108,838)
Balance, end of period (in shares) at Apr. 30, 2022	12,727,615	12,727,615